SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-24-001753
Filing Date
2024-02-27
Accepted
2024-02-27 07:30:29
Documents
97
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K acrs-20231231x10k.htm   iXBRL 10-K 2747418
2 EX-4.1 acrs-20231231xex4d1.htm EX-4.1 25437
3 EX-10.15 acrs-20231231xex10d15.htm EX-10.15 119404
4 EX-10.18 acrs-20231231xex10d18.htm EX-10.18 87471
5 EX-10.22 acrs-20231231xex10d22.htm EX-10.22 27599
6 EX-21.1 acrs-20231231xex21d1.htm EX-21.1 5806
7 EX-23.1 acrs-20231231xex23d1.htm EX-23.1 2657
8 EX-31.1 acrs-20231231xex31d1.htm EX-31.1 9675
9 EX-31.2 acrs-20231231xex31d2.htm EX-31.2 9768
10 EX-32.1 acrs-20231231xex32d1.htm EX-32.1 9261
11 EX-97.1 acrs-20231231xex97d1.htm EX-97.1 38497
12 GRAPHIC acrs-20231231x10k002.jpg GRAPHIC 41449
13 GRAPHIC acrs-20231231xex10d22003.jpg GRAPHIC 12332
  Complete submission text file 0001558370-24-001753.txt   11456807

Data Files

Seq Description Document Type Size
14 EX-101.SCH acrs-20231231.xsd EX-101.SCH 56304
15 EX-101.CAL acrs-20231231_cal.xml EX-101.CAL 72705
16 EX-101.DEF acrs-20231231_def.xml EX-101.DEF 248636
17 EX-101.LAB acrs-20231231_lab.xml EX-101.LAB 595270
18 EX-101.PRE acrs-20231231_pre.xml EX-101.PRE 421738
99 EXTRACTED XBRL INSTANCE DOCUMENT acrs-20231231x10k_htm.xml XML 2153847
Mailing Address 701 LEE ROAD SUITE 103 WAYNE PA 19087
Business Address 701 LEE ROAD SUITE 103 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

IRS No.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37581 | Film No.: 24681989
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)